Skip to content

ICAAC: When to use T-20: new analysis shows risk of leaving it too late

ICAAC: Kaletra exposure decreased by tenofovir in experienced HIV patients

ICAAC: Tenofovir and Trizivir effective and well-tolerated in patients who fail first regimen

ICAAC: Resistance found in one in seven of treatment-naive US patients

ICAAC: Saquinavir and ritonavir must be taken simultaneously for best saquinavir levels

ICAAC: Combination of tenofovir and Trizivir as effective and tolerable as Combivir / efavirenz

ICAAC: Fall in immune cells predicts reaction to abacavir, and high incidence of reaction if abacavir used during primary infection

ICAAC: Treatment breaks riskier if NNRTIs involved

ICAAC: Mitochondrial DNA level in blood may provide early warning of lipodystrophy